Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

STAAR SURGICAL CO

$29.96 -0.10% NASDAQ: STAA · 15-min delayed
  • MONROVIA, California
  • Public · NASDAQ: STAA
  • 957 employees
$1.5BMarket cap
$239.4MRevenue · FY2026
-$80.4MNet income
957Employees
STAANASDAQ
1983IPO

About STAAR SURGICAL CO

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2026
$239.4M
Net income
-$80.4M
Total assets
$451.7M
Market cap
$1.5B
Gross margin
76.2%
Operating margin
-38.3%
Net margin
-33.6%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$239.4M
Cost of revenue
$57.0M
Gross profit
$182.4M
Operating expenses
$274.1M
Operating income
-$91.7M
Income tax
-$1.8M
Net income
-$80.4M
EPS (basic)
$-1.62
EPS (diluted)
$-1.62

Balance sheet

Total assets
$451.7M
Current assets
$311.5M
Total liabilities
$107.5M
Current liabilities
$68.5M
Shareholders’ equity
$344.2M

Cash flow

Operating cash flow
-$34.2M
Investing cash flow
$46.3M
Financing cash flow
-$4.6M
Net cash flow
$9.0M

Statements via Polygon.io (SEC filings)

NASDAQ: STAA
$29.96 -0.10%

15-minute delayed · data by Polygon.io

Past year

$16.10 $33.34

52-week range

Market cap
$1.5B
EPS (diluted)
$-1.62
Shares outstanding
49.8M
Open
Day range
Prev close
Volume
IPO date
Jul 7, 1983

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

  • Reported a net loss of $80.4M in FY2026.
  • Revenue grew 4% from FY2021 to FY2025.
  • Gross margin of 76.2%, net margin -33.6%.
  • Trading 10% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review STAAR SURGICAL CO.

Write a review
Newsroom

News about STAAR SURGICAL CO

News & sentiment via Polygon.io

Explore

Similar companies

Browse all →